awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26796432-59678229-D63B-4764-8DB6-5642795A32CE
Q26796432-59678229-D63B-4764-8DB6-5642795A32CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796432-59678229-D63B-4764-8DB6-5642795A32CE
Patient considerations in the management of ulcerative colitis - role of vedolizumab
P2860
Q26796432-59678229-D63B-4764-8DB6-5642795A32CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796432-59678229-D63B-4764-8DB6-5642795A32CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd58a5df1bcca5b1bc71e74dba1502b44d9ed1ce
P2860
The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.